Fibroids: Silent Uterus Tumors Affect 80% of Women

Noncancerous uterine fibroids are highly common, affecting up to 80 percent of women by age 50. These tumors can grow within or on the uterus, sometimes causing heavy menstrual bleeding, pelvic pain, pressure, and even impacting fertility and daily life. The exact causes remain unknown but likely involve a mix of genetic, hormonal, and environmental factors. Black women face a disproportionately higher risk, often experiencing more severe symptoms at younger ages.

Diagnosis typically involves imaging tests like ultrasounds or MRIs, especially if symptoms are present or a mass is detected during a pelvic exam. Treatment strategies are diverse, ranging from monitoring small, asymptomatic fibroids to medications that manage bleeding and reduce fibroid size. Procedures like uterine artery embolization or radiofrequency ablation aim to shrink growths but may not be suitable for those desiring future pregnancies.

Surgical removal through myomectomy is another option, though fibroids can recur in a significant percentage of cases. Hysterectomy, the removal of the uterus, is the only definitive way to prevent recurrence but is often presented prematurely as the sole solution. Experts emphasize the importance of informed decision-making, encouraging women to explore all available treatment options, including seeking second opinions, to find the best path forward.